Review article · 9 Aug 2024
Conference abstractPublished 2015
Development and implementation of metabolomics platform: Considerations for successful discovery and validation of biomarkers
Sanofi, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
As translational science approach to drug discovery and development is being broadly implemented in pharmaceutical industry we are increasingly relying on metabolic biomarkers in all phases of the process, including target credentialing, proof of concept, establishment of biomarkers based screens, in vivo studies, clinical studies and establishment of biomarker based diagnostics. In cases when biomarkers are not known, metabolomics platform becomes an essential tool for holistic and unbiased interrogation of thousands of metabolites and identification of metabolic biomarkers. Identification of biomarkers is based on global profiling using chromatographic separation coupled with high resolution accurate mass spectrometric detection (HRAM). Processing of the data is carried out using sophisticated peak picking software, statistical packages and working with data bases. Since there is no single “of the shelf ” product enabling to carry out all the data processing steps for metabolomics, this is especially challenging. Exact molecular mass information available in public data bases typically allows only for tentative identification of the biomarkers and often results in multiple options which have to be evaluated in additional experiments. This is both expensive and time consuming. In this presentation we will describe analytical platform for metabolomics established at AR&D / LGCR in Sanofi as a result of multiple applications and cross-departmental collaborations. We will discuss considerations for development of methodology for sample preparation and analysis using LC-HRAM, as well as approach for construction of an in-house metabolomics data base and demonstrate our data processing approach based on trends and correlation analysis allowing for identification of phenotype-linked biomarkers with much reduced effort.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Diagnostic Techniques and Biomedical Analysis.
Opinion · 29 Dec 2023
Molecular Diagnostics: Decoding Disease at the Genetic Level
Opinion · 29 Dec 2023
From Data Streams to Diagnoses: AI's Journey in Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diagnostic Techniques and Biomedical Analysis
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Alla Kloss”
- BylineArticles whose byline prints “Sarah Gentry”
- BylineArticles whose byline prints “Kristen Randall”
- BylineArticles whose byline prints “Harvey Lieberman”
- BylineArticles whose byline prints “Aharon Cohen”
